Vitrolife AB (VITR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr172.00 Million ≈ $18.51 Million USD) by net assets (Skr8.07 Billion ≈ $868.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VITR equity financing ratio to measure how much of total assets are equity-financed.
Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VITR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Vitrolife AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Natural Resource Partners LP
NYSE:NRP
|
0.052x |
|
Shenzhen Clou Electronics Co Ltd
SHE:002121
|
0.146x |
|
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
|
0.032x |
|
Guizhou Redstar Developing Co Ltd
SHG:600367
|
0.010x |
|
One Software Technologies Ltd
TA:ONE
|
0.082x |
|
Xiamen Kingdomway Group Co
SHE:002626
|
0.040x |
|
Jade Bird Fire Alarm
SHE:002960
|
-0.011x |
|
RPC Inc
NYSE:RES
|
0.028x |
Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)
The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Vitrolife AB.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.89 Billion ≈ $849.63 Million |
Skr635.00 Million ≈ $68.34 Million |
0.080x | +20.97% |
| 2024-12-31 | Skr13.64 Billion ≈ $1.47 Billion |
Skr907.00 Million ≈ $97.61 Million |
0.066x | +11.75% |
| 2023-12-31 | Skr12.72 Billion ≈ $1.37 Billion |
Skr757.00 Million ≈ $81.47 Million |
0.059x | +56.60% |
| 2022-12-31 | Skr16.74 Billion ≈ $1.80 Billion |
Skr636.00 Million ≈ $68.44 Million |
0.038x | +51.66% |
| 2021-12-31 | Skr15.34 Billion ≈ $1.65 Billion |
Skr384.31 Million ≈ $41.36 Million |
0.025x | -85.82% |
| 2020-12-31 | Skr2.02 Billion ≈ $217.06 Million |
Skr356.45 Million ≈ $38.36 Million |
0.177x | -23.14% |
| 2019-12-31 | Skr1.80 Billion ≈ $193.45 Million |
Skr413.33 Million ≈ $44.48 Million |
0.230x | -1.55% |
| 2018-12-31 | Skr1.50 Billion ≈ $161.02 Million |
Skr349.44 Million ≈ $37.60 Million |
0.234x | -8.09% |
| 2017-12-31 | Skr1.23 Billion ≈ $132.22 Million |
Skr312.19 Million ≈ $33.60 Million |
0.254x | +43.04% |
| 2016-12-31 | Skr1.02 Billion ≈ $109.81 Million |
Skr181.26 Million ≈ $19.51 Million |
0.178x | -22.44% |
| 2015-12-31 | Skr844.97 Million ≈ $90.93 Million |
Skr193.53 Million ≈ $20.83 Million |
0.229x | +10.47% |
| 2014-12-31 | Skr702.57 Million ≈ $75.61 Million |
Skr145.67 Million ≈ $15.68 Million |
0.207x | -36.98% |
| 2013-12-31 | Skr322.60 Million ≈ $34.72 Million |
Skr106.13 Million ≈ $11.42 Million |
0.329x | +53.14% |
| 2012-12-31 | Skr278.98 Million ≈ $30.02 Million |
Skr59.93 Million ≈ $6.45 Million |
0.215x | +87.22% |
| 2011-12-31 | Skr343.90 Million ≈ $37.01 Million |
Skr39.46 Million ≈ $4.25 Million |
0.115x | -22.63% |
| 2010-12-31 | Skr326.33 Million ≈ $35.12 Million |
Skr48.40 Million ≈ $5.21 Million |
0.148x | +11.59% |
| 2009-12-31 | Skr312.07 Million ≈ $33.58 Million |
Skr41.48 Million ≈ $4.46 Million |
0.133x | -9.19% |
| 2008-12-31 | Skr292.39 Million ≈ $31.47 Million |
Skr42.79 Million ≈ $4.61 Million |
0.146x | +74.23% |
| 2007-12-31 | Skr253.38 Million ≈ $27.27 Million |
Skr21.29 Million ≈ $2.29 Million |
0.084x | -22.07% |
| 2006-12-31 | Skr220.64 Million ≈ $23.74 Million |
Skr23.78 Million ≈ $2.56 Million |
0.108x | +34.70% |
| 2005-12-31 | Skr176.45 Million ≈ $18.99 Million |
Skr14.12 Million ≈ $1.52 Million |
0.080x | -13.96% |
| 2004-12-31 | Skr150.57 Million ≈ $16.20 Million |
Skr14.01 Million ≈ $1.51 Million |
0.093x | -57.25% |
| 2003-12-31 | Skr143.44 Million ≈ $15.44 Million |
Skr31.20 Million ≈ $3.36 Million |
0.218x | -30.30% |
| 2002-12-31 | Skr111.40 Million ≈ $11.99 Million |
Skr34.77 Million ≈ $3.74 Million |
0.312x | -- |
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more